Full text loading...
, Carmen Carretón-Ballester1
and Natalia Papí-Gálvez1
Issues such as global health and universal accessibility to medicines and vaccines have become particularly important in the commitment of the pharmaceutical industry since the last health crisis. The 2030 Agenda has also marked a turning point in the industry, which has had to align its corporate strategies to achieve the Sustainable Development Goals (SDGs). This exploratory-descriptive study, with a mixed approach, presents an insight into the social responsibility of the pharmaceutical companies with the best reputation in Spain, in their relationship with their publics and their contribution to sustainable development, with the content analysis of their responsibility reports and the diffusion of responsible actions on the web. The results show that there are indicators, such as pharmacovigilance in the global dimension, or SDG 5 on gender equality and empowerment of all women and girls, that are barely addressed.
Article metrics loading...
Full text loading...
Data & Media loading...
Publication Date:
https://doi.org/10.1386/cjcs_00104_1 Published content will be available immediately after check-out or when it is released in case of a pre-order. Please make sure to be logged in to see all available purchase options.